Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

Filter Results:

Show Only Available Presentations

  • +

    FP09 - Novel Therapeutics and Targeted Therapies

    • Type: Posters (Featured)
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 4
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
  • +

    P50 - Novel Therapeutics and Targeted Therapies - EGFR Minor

    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 8
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P50.03 - A Real-World Cohort Study of EGFR TKIs in Patients with NSCLC with Uncommon EGFR mutations (UpSwinG)

      00:00 - 00:00  |  Presenter: Satoru Miura

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P51 - Novel Therapeutics and Targeted Therapies - EGFR Resistance

    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 7
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P51.05 - Sequential Afatinib and Osimertinib in Patients With Advanced EGFRm+ NSCLC and Acquired T790M: The Real-World UpSwinG study

      00:00 - 00:00  |  Presenter: Sanjay Popat

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA17 - Multidisciplinary Care of Thoracic Oncology Patients During COVID-19 Pandemic

    • Type: Oral
    • Track: Nursing and Allied Health Professionals
    • Presentations: 6
  • +

    ES20 - Caveats, Challenges, and Controversies in Immunotherapy of Lung Cancer: Phase II and Phase III Trials*

    • Type: Education Session
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 5
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • Moderators:David R. Gandara
    • Coordinates: 9/14/2021, 20:30 - 21:05, Program Auditorium